. Levi's fiscal-third quarter revenue missed expectations, but earnings per share came in slightly above. Levi's CEO said consumers were buying fewer items due to inflation and rising mortgage and gas prices.— The Dutch health tech company dropped more than 8.7% after the U.S. Food and Drug Administration said its handling of its 2021 sleep apnea device recallof some Model 3 and Model Y vehicles in the U.S.
The move followed the company's third-quarter vehicle production and deliveries update, which missed analysts' expectations.— Shares of the biopharmaceutical company rose 5.5% after Apellis reported growing sales for its Syfovre drug in August. JPMorgan upgraded the stock to overweight from neutral, saying that the success of Syfovre should shift sentiment around Apellis heading into 2024.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: MarketWatch - 🏆 3. / 97 続きを読む »
ソース: MarketWatch - 🏆 3. / 97 続きを読む »
ソース: MarketWatch - 🏆 3. / 97 続きを読む »